A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols.


Autoria(s): Attig S.; Price L.; Janetzki S.; Kalos M.; Pride M.; McNeil L.; Clay T.; Yuan J.; Odunsi K.; Hoos A.; Romero P.; Britten C.M.; CRI-CIC Assay Working Group
Data(s)

2011

Identificador

https://serval.unil.ch/?id=serval:BIB_CD027B1F8E53

isbn:1479-5876 (Electronic)

pmid:21745365

doi:10.1186/1479-5876-9-108

isiid:000293353500001

http://my.unil.ch/serval/document/BIB_CD027B1F8E53.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CD027B1F8E531

Idioma(s)

en

Direitos

info:eu-repo/semantics/openAccess

Fonte

Journal of Translational Medicine, vol. 9, pp. 108

Palavras-Chave #Biological Markers/metabolism; CD8-Positive T-Lymphocytes/cytology; CD8-Positive T-Lymphocytes/immunology; Cell Survival; Coloring Agents/metabolism; Computational Biology; HLA Antigens/metabolism; Humans; Lymphocyte Count; Peptides/metabolism; Protein Binding; Protein Multimerization; Reproducibility of Results; Staining and Labeling/methods; Subcellular Fractions/metabolism
Tipo

info:eu-repo/semantics/article

article